| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Mar 3, 2025 | PDS Biotechnology Corp | Director | Buy | 91.3 | +15,060 | 32.63% | ✗ | $25K |
| Mar 7, 2024 | Mar 8, 2024 | Axogen, Inc. | Director | Sell | 22.5 | -25,000 | -8.43% | ✗ | $225K |
| Jun 1, 2023 | Jun 5, 2023 | Axogen, Inc. | Director | Sell | 20.0 | -41,980 | -12.64% | ✗ | $365.8K |
| May 23, 2023 | May 24, 2023 | Axogen, Inc. | Director | Sell | 22.5 | -7,468 | -2.20% | ✗ | $68.9K |
| Nov 14, 2022 | Nov 16, 2022 | Axogen, Inc. | Director | Sell | 37.5 | -13,000 | -3.69% | ✓ | $165.6K |
| Nov 8, 2022 | Nov 10, 2022 | Axogen, Inc. | Director | Sell | 37.5 | -13,000 | -3.56% | ✓ | $162.5K |
| Aug 10, 2022 | Aug 11, 2022 | Axogen, Inc. | Director | Sell | 41.3 | -8,886 | -2.37% | ✓ | $86.2K |
| Aug 4, 2022 | Aug 8, 2022 | Axogen, Inc. | Director | Sell | 26.3 | -37,046 | -9.00% | ✓ | $390.6K |
| Jul 25, 2022 | Jul 26, 2022 | Axogen, Inc. | Director | Sell | 20.0 | -30,296 | -6.86% | ✗ | $280.5K |
| Jun 17, 2021 | Jun 21, 2021 | Axogen, Inc. | Director | Sell | 42.5 | -8,781 | -2.41% | ✗ | $183.7K |
| Jun 15, 2021 | Jun 17, 2021 | PDS Biotechnology Corp | Director | Buy | 91.3 | +5,882 | 14.61% | ✗ | $50K |
| Feb 25, 2021 | Mar 1, 2021 | Axogen, Inc. | Director | Sell | 26.3 | -24,000 | -9.51% | ✓ | $529.4K |
| Feb 16, 2021 | Feb 18, 2021 | Axogen, Inc. | Director | Sell | 61.3 | +3,584 | 0.36% | ✗ | $29.5K |
| Dec 27, 2020 | Dec 30, 2020 | Axogen, Inc. | Director | Sell | 68.8 | +1,384 | 0.56% | ✗ | $16.3K |
| Dec 18, 2020 | Dec 22, 2020 | Axogen, Inc. | Director | Sell | 60.0 | +546 | 0.22% | ✗ | $6.2K |
| Feb 18, 2020 | Feb 20, 2020 | Axogen, Inc. | General Counsel | Sell | 83.8 | +3,629 | 3.53% | ✗ | $22.5K |
| Dec 18, 2019 | Dec 20, 2019 | Axogen, Inc. | General Counsel | Sell | 77.5 | +1,283 | 1.28% | ✗ | $9.5K |
| Nov 30, 2018 | Dec 4, 2018 | Axogen, Inc. | General Counsel | Sell | 5.0 | -45,000 | -31.95% | ✓ | $1.5M |
| Nov 15, 2018 | Nov 15, 2018 | Axogen, Inc. | General Counsel | Sell | 20.0 | -20,000 | -12.43% | ✗ | $645K |
| Mar 21, 2018 | Mar 23, 2018 | Axogen, Inc. | General Counsel & SVP BD | Sell | 32.5 | -2,896 | -0.93% | ✗ | $111.5K |
| Mar 1, 2018 | Mar 5, 2018 | Axogen, Inc. | General Counsel & SVP BD | Sell | 22.5 | -2,905 | -2.14% | ✗ | $98.6K |
| Sep 25, 2017 | Sep 27, 2017 | Axogen, Inc. | General Counsel & SVP BD | Sell | 26.3 | -1,450 | -1.43% | ✗ | $27.4K |
| Aug 27, 2017 | Aug 29, 2017 | Axogen, Inc. | General Counsel & SVP BD | Sell | 22.5 | -3,785 | -3.99% | ✗ | $63K |
| Jun 2, 2014 | Jun 4, 2014 | Axogen, Inc. | CFO | Buy | 91.3 | +5,200 | 21.38% | ✗ | $12.7K |
| Aug 14, 2013 | Aug 15, 2013 | Axogen, Inc. | CFO | Buy | 91.3 | +8,334 | 34.27% | ✗ | $25K |
| Dec 30, 2011 | Jan 3, 2012 | Axogen, Inc. | CFO | Buy | 91.3 | +9,318 | 62.12% | ✗ | $22.4K |